High glucose inhibits apoptosis in human coronary artery smooth muscle cells by increasing bcl-xL and bfl-1/A1

American Journal of Physiology - Cell Physiology

Volumn 283, Issue 2 52-2, 2002, Pages

  Sakuma, Hiroya ^a   Yamamoto, Mayumi ^a   Okumura, Mie ^a   Kojima, Toshihiro ^a   Maruyama, Takako ^a   Yasuda, Keigo ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Atherosclerosis; Diabetes mellitus; Vascular smooth muscle cells

Indexed keywords

DNA FRAGMENT; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL XL; PROTEIN BFL A1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY; DIABETES MELLITUS; GLYCATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

EID: 0036077560     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00577.2001     Document Type: Article

References (51)

1. Regulation of vascular smooth muscle cell apoptosis. Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway
2. High-glucose-triggered apoptosis in cultured endothelial cells
3. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways
4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
5. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid
6. A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow
7. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis
8. Is the regulation of apoptosis altered in smooth muscle cells of adult spontaneously hypertensive rats?
9. Bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity
10. A matter of life and cell death
11. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study
12. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1β-converting enzyme
13. Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway
14. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model
15. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty
16. Apoptosis: Basic mechanisms and implications for cardiovascular disease
17. 0 phase, in vascular smooth muscle cells
18. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
19. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways
20. Apoptosis and Bcl-xs in the intimal thickening of balloon-injured carotid arteries
21. Apoptosis in human atherosclerosis and restenosis
22. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway
23. Apoptosis and related proteins in different stages of human atherosclerotic plaques
24. The role of apoptosis in vascular disease
25. Protein kinase C activation and the development of diabetic complications
26. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
27. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress
28. NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
29. Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells
30. The regulation of vascular smooth muscle cell apoptosis
31. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients
32. Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells
33. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose
34. Molecular mechanisms in intimal hyperplasia
35. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy
36. Platelet-derived growth factor induces apoptosis in vascular smooth muscle cells: Roles of the Bcl-2 family
37. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways
38. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularisation
39. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease
40. Double identity for proteins of the Bcl-2 family
41. Atherosclerosis - An inflammatory disease
42. Regulation of NF-kappa B activation by MAP kinase cascades
43. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes
44. Advanced glycation end-products and atherosclerosis
45. NF-κB induces expression of the bcl-2 homologue A1/bfl-1 to preferentially suppress chemotherapy-induced apoptosis
46. The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study
47. Is hyperglycemia associated with cardiovascular disease? The Framingham Study
48. Opposing effects of ERK and JNK-p 38 MAP kinases on apoptosis
49. Acute glucose-induced downregulation of PKC-βII accelerates cultured VSMC proliferation
50. Hyperglycemia-induced activation of nuclear transcription factor KB in vascular smooth muscle cells
51. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis